154 related articles for article (PubMed ID: 24287144)
1. Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients.
Onoe S; Shimoyama Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nakamura S; Nagino M
Surgery; 2014 Feb; 155(2):280-91. PubMed ID: 24287144
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kondo Y; Miyazaki M
Am J Surg Pathol; 2011 Apr; 35(4):512-21. PubMed ID: 21412069
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
6. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma.
Yeh CN; Jan YY; Yeh TS; Hwang TL; Chen MF
Ann Surg Oncol; 2004 Jun; 11(6):606-11. PubMed ID: 15172934
[TBL] [Abstract][Full Text] [Related]
7. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma.
Suh KS; Roh HR; Koh YT; Lee KU; Park YH; Kim SW
Hepatology; 2000 Jan; 31(1):12-7. PubMed ID: 10613721
[TBL] [Abstract][Full Text] [Related]
10. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Preoperative
Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
[TBL] [Abstract][Full Text] [Related]
16. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
[TBL] [Abstract][Full Text] [Related]
17. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
[TBL] [Abstract][Full Text] [Related]
19. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]